| Bioactivity | A2A/A1 AR antagonist-1 (compound 1a) is dual potent A2A/A1 AR antagonist with Kis of 5.58 and 24.2 nM, respectively. A2A/A1 AR antagonist-1 has the potential for the research of ischemic stroke[1]. |
| Name | A2A/A1 AR antagonist-1 |
| CAS | 2445615-24-5 |
| Formula | C15H12N6O2 |
| Molar Mass | 308.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tang ML, et al. Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke. ACS Med Chem Lett. 2022;13(3):436-442. Published 2022 Feb 21. |
A2A/A1 AR antagonist-1
CAS: 2445615-24-5 F: C15H12N6O2 W: 308.29
A2A/A1 AR antagonist-1 (compound 1a) is dual potent A2A/A1 AR antagonist with Kis of 5.58 and 24.2 nM, respectively. A2A
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.